Correlation Between Denali Therapeutics and Cytodyn
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Cytodyn at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Cytodyn into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Cytodyn, you can compare the effects of market volatilities on Denali Therapeutics and Cytodyn and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Cytodyn. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Cytodyn.
Diversification Opportunities for Denali Therapeutics and Cytodyn
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Denali and Cytodyn is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Cytodyn in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytodyn and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Cytodyn. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytodyn has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Cytodyn go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Cytodyn
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.56 times more return on investment than Cytodyn. However, Denali Therapeutics is 1.79 times less risky than Cytodyn. It trades about 0.01 of its potential returns per unit of risk. Cytodyn is currently generating about 0.0 per unit of risk. If you would invest 2,980 in Denali Therapeutics on September 2, 2024 and sell it today you would lose (480.00) from holding Denali Therapeutics or give up 16.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Cytodyn
Performance |
| Timeline |
| Denali Therapeutics |
| Cytodyn |
Denali Therapeutics and Cytodyn Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Cytodyn
The main advantage of trading using opposite Denali Therapeutics and Cytodyn positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Cytodyn can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytodyn will offset losses from the drop in Cytodyn's long position.| Denali Therapeutics vs. Tff Pharmaceuticals | Denali Therapeutics vs. Eliem Therapeutics | Denali Therapeutics vs. Inhibrx | Denali Therapeutics vs. Enliven Therapeutics |
| Cytodyn vs. Madrigal Pharmaceuticals | Cytodyn vs. Scpharmaceuticals | Cytodyn vs. Akero Therapeutics | Cytodyn vs. Cardiff Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |